close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

31.38 +0.15 (+0.48%)
Official Closing Price Updated: 7:00 PM EST, Jan 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
48 49 Next >
News headline image
Hims &amp; Hers Health, Inc. (HIMS) Investors: August 25, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer &amp; Check, LLP
Via TheNewswire.com
Topics Lawsuit
News headline image
Hims & Hers Health, Inc. (HIMS) Investors: August 25, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
With Dementia On The Rise Are There Steps An Aging Population Can Take To Reduce Risk?
Comtex News Network, Inc. is a content specialist offering actionable news distribution, global syndication, and traffic for your content 
Via News Direct
News headline image
Hims & Hers Health, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before August 25, 2025 to Discuss Your Rights - HIMS
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
News headline image
Hims &amp; Hers Health, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi &amp; Korsinsky Before August 25, 2025 to Discuss Your Rights - HIMS
Via TheNewswire.com
Topics Fraud Lawsuit
With Dementia On The Rise Are There Steps An Aging Population Can Take To Reduce Risk?
Via AB Newswire
News headline image
HIMS & HERS HEALTH SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Hims & Hers Health, Inc. - HIMS
From SkyMedia, LLC
Via GlobeNewswire
News headline image
2 Surging Stocks to Research Further and 1 We Turn Down
Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a new product line, constructive news flow, or... 
Via StockStory
News headline image
Hims & Hers Health, Inc. (HIMS) Investors: August 25, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
Hims &amp; Hers Health, Inc. (HIMS) Investors: August 25, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer &amp; Check, LLP
Via TheNewswire.com
Topics Lawsuit
News headline image
Novo Nordisk Slumps As It Cautions 'Unsafe And Unlawful' Knockoffs Will Pressure Wegovy ↗
The company says it's working to ensure patients only receive semaglutide produced by Novo Nordisk. 
Via Investor's Business Daily
Topics Earnings
News headline image
Hims &amp; Hers Health, Inc. Class Action: Levi &amp; Korsinsky Reminds Hims &amp; Hers Health, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of August 25, 2025 - HIMS
Via TheNewswire.com
Topics Fraud Lawsuit
News headline image
Hims & Hers Health, Inc. Class Action: Levi & Korsinsky Reminds Hims & Hers Health, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of August 25, 2025 - HIMS
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
News headline image
Diagnosis: Hims & Hers' August Price Dip Is an Opportunity to Buy ↗
Hims & Hers falls into a buying opportunity followng the Q2 release and guidance update but investors shouldn't rush to get in, wait for this market to bottom. 
Via MarketBeat
News headline image
These Are the Smartest Growth Stocks to Invest $1,000 in Today ↗
These growth stocks come from completely different industries, but each has something to offer long-term investors. 
Via The Motley Fool
News headline image
Novo Nordisk Edges Up Premarket As Q2 Wegovy Sales Defy Copycat Threats: Retail Stays Bullish Amid Tariff Pressure ↗
The results follow Novo’s worst weekly decline in its history after the company slashed its full-year guidance. 
Via Stocktwits
Topics Government World Trade
News headline image
Market Monitor News August 06 BMO - Wall Street Slides as Services Sector Falters, but Palantir Rockets Past Expectations ↗
A weaker-than-expected ISM services report reignited fears of a slowing U.S. economy, dragging major indices into the red. 
Via Chartmill
Topics Economy
News headline image
HIMS & HERS HEALTH SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Hims & Hers Health, Inc. - HIMS
From Kahn Swick & Foti, LLC
Via GlobeNewswire
News headline image
HIMS LAWSUIT ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Hims & Hers Health, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Gibbs Mura Reminds Hims & Hers Health, Inc. (NYSE: HIMS) Investors of Opportunity to Join a Class Action Lawsuit Seeking Recovery
From Gibbs Mura
Via Business Wire
News headline image
Stock Market Today: Hims & Hers Tumbles 12% on Revenue Miss Despite 73% Growth ↗
Hims & Hers stock fell sharply Tuesday after the company missed Q2 revenue estimates, despite strong growth and reaffirmed guidance. 
Via The Motley Fool
News headline image
HIMS DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Hims & Hers Health, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – HIMS
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
Earnings Season Wrap-Up: Tech Giants Shine, Others Face Mixed Results
The latest earnings season, spanning late July and early August 2025, has painted a vivid picture of a bifurcated market, where the titans of technology continue to defy gravity, largely propelled by... 
Via MarketMinute
Topics Artificial Intelligence Economy
News headline image
US Market Under Pressure: Amazon, Eastman Chemical, and Hims & Hers Among Top Losers
The U.S. stock market experienced a turbulent start to August 2025, marked by significant declines for several prominent companies. This downturn, following a volatile end to July, has left investors... 
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
Palantir, Pfizer, Hims & Hers, Intel, UnitedHealth: Stocks Making The Biggest Moves Today ↗
Via Stocktwits
News headline image
Stocks Drop As Trump Tariffs Fuel Inflation, Palantir Hits $400 Billion Value: What's Moving Market Tuesday? ↗
Stocks slipped Tuesday as fresh economic data reignited stagflation fears on Wall Street, overshadowing a blowout quarter from Palantir Technologies Inc. 
Via Benzinga
Topics Economy Government
News headline image
Hims & Hers Stock Is Trading Lower Tuesday: What's Going On? ↗
 
Via Benzinga
News headline image
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Hims & Hers Health
From Faruqi & Faruqi LLP
Via GlobeNewswire
News headline image
Hims & Hers Health Posts Weak Q2; Heading Into More Near-Term Challenges, Analysts Say ↗
Hims & Hers Health (HIMS) stock falls after reporting lower Q2 revenues. Analysts caution about near-term challenges, including regulatory complexity. 
Via Benzinga
News headline image
Why Hims & Hers Health Stock Just Dropped ↗
Hims & Hers stock just got cheaper -- and it's still too expensive to buy. 
Via The Motley Fool
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
48 49 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today